Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF α pour rhumatisme inflammatoire chronique

Hydroxychloroquine is an agent used as a treatment but also considered as a prophylaxis for SARS-CoV-2 infection. We report the case of a patient who developed COVID-19 while on hydroxychloroquine for mixed connectivitis associated with spondyloarthritis. Although more work is needed before any conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Malek, Saadia Ait, Bouchti, Imane El
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608760/
https://www.ncbi.nlm.nih.gov/pubmed/33193949
http://dx.doi.org/10.11604/pamj.supp.2020.35.134.25011
Descripción
Sumario:Hydroxychloroquine is an agent used as a treatment but also considered as a prophylaxis for SARS-CoV-2 infection. We report the case of a patient who developed COVID-19 while on hydroxychloroquine for mixed connectivitis associated with spondyloarthritis. Although more work is needed before any conclusions can be drawn, this raises questions about the protective role of this drug against infection. Are they really protected against COVID-19 or will they develop pauci-symptomatic forms?

Ejemplares similares